Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19.
Dennis M BierleRavindra GaneshCaroline G WilkerSara N HansonDarcie E MoehnkeTammy A JacksonPriya RamarJordan K RosedahlLindsey M PhilpotRaymund R RazonablePublished in: Journal of primary care & community health (2021)
Despite having more comorbidities, patients who accepted monoclonal antibody treatments had a lower rate of hospitalization compared to patients who declined treatment. Several social and cultural factors were associated with the decision to decline therapy, including race, language, ethnicity, and lack of social support. These findings can inform public health efforts to reduce social disparities in the treatment of COVID-19 and increase utilization of monoclonal antibody therapies in high risk populations.